Advertisement

Author: PWeekly

Nerve Dysfunction May Be a Source of Dry Eye Symptoms

A more robust conditioned pain modulation (CPM) response—a measure of descending (inhibitory) pain pathways—was associated with worse dry eye (DE) metrics, according to a study, suggesting that CPM is intact or even upregulated...

Read More

Age & MS Status Independently Impact HRQOL

Data indicate that individuals with MS experience decreased HRQOL compared with the general population, but research is lacking on changes in MS as a function of aging. To investigate this relationship, researchers examined...

Read More

Conditioned Pain Modulation Intact in Dry Eye

To assess the role of conditioned pain modulation (CPM), a measure of inhibitory pain pathways, in dry eye management (DE), researchers conducted a cross-sectional study of 268 patients from October 2017 to August 2018. They...

Read More

Teprotumumab for Long-Standing, Active TED

While phase II and III trials indicate that teprotumumab therapy can significantly reduce proptosis and Clinical Activity Score (CAS) in patients with recent-onset (< 8 months), untreated TED (except for steroid therapy >...

Read More

Recalcitrant TED Responsive to Teprotumumab

New research presented at the American Society of Ophthalmic Plastic & Reconstructive Surgery’s fall symposium highlighted the benefits of Tepezza (teprotumumab) for patients with thyroid eye and Graves disease....

Read More

ASN Kidney Week Learning Pathways

The following learning pathways will help attendees locate sessions in their area of interest: Acute Kidney Injury Bone and Mineral Metabolism Cell and Transport Physiology Chronic Kidney Disease Development and Pediatrics...

Read More

For latest news and updates
Email-id is invalid